Panel recommends sweeping changes in clinical trials process
Umbrella body mooted to oversee accreditation of institutions and for setting up ethics committees
An official expert committee has recommended major changes in the guidelines for approval of new drugs, clinical trials and banning of medicines.
It suggested setting up of a council to oversee the accreditation of institutions, clinical investigators and institute ethics committees for clinical trials in the country.
Publication Date:
17/09/2013